Antibiotic Delivery System for Treating Bacteria-Induced Anterior Blepharitis

ACS Infect Dis. 2023 Oct 13;9(10):2005-2015. doi: 10.1021/acsinfecdis.3c00299. Epub 2023 Oct 3.

Abstract

The eyelid-related disease of blepharitis remains a tricky ocular disorder and affects patient compliance. However, there is no available and effective treatment, making it extremely challenging. Herein, an antibacterial system based on antibiotic delivery was developed and applied in a blepharitis model induced by bacteria. The antibacterial tests against Staphylococcus aureus both in vitro and in vivo demonstrated that the system shows a favorable bactericidal effect. Then, histological evaluation indicated that the system shows both antibacterial and anti-inflammatory effects. This facile design provided an effective ocular infection management, which displays a promising prospect while addressing other complex ocular disorders.

Keywords: anti-inflammatory; antibiotic delivery system; blepharitis; ocular surface homeostasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Bacteria
  • Blepharitis* / drug therapy
  • Blepharitis* / microbiology
  • Humans
  • Staphylococcus aureus
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents